ATE248601T1 - Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4 - Google Patents

Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4

Info

Publication number
ATE248601T1
ATE248601T1 AT96923329T AT96923329T ATE248601T1 AT E248601 T1 ATE248601 T1 AT E248601T1 AT 96923329 T AT96923329 T AT 96923329T AT 96923329 T AT96923329 T AT 96923329T AT E248601 T1 ATE248601 T1 AT E248601T1
Authority
AT
Austria
Prior art keywords
nsp4
terotoxin
viral
vaccine against
containing peptides
Prior art date
Application number
AT96923329T
Other languages
English (en)
Inventor
Mary K Estes
Judith Ball
Peng Tiang
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Application granted granted Critical
Publication of ATE248601T1 publication Critical patent/ATE248601T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96923329T 1995-06-14 1996-06-14 Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4 ATE248601T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22095P 1995-06-14 1995-06-14
US62801496A 1996-04-04 1996-04-04
PCT/US1996/010523 WO1997000088A2 (en) 1995-06-14 1996-06-14 Rotavirus enterotoxin nsp4 and methods of using same

Publications (1)

Publication Number Publication Date
ATE248601T1 true ATE248601T1 (de) 2003-09-15

Family

ID=26667352

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96923329T ATE248601T1 (de) 1995-06-14 1996-06-14 Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4

Country Status (8)

Country Link
US (1) US6210682B1 (de)
EP (1) EP0833670B1 (de)
JP (1) JPH11507831A (de)
AT (1) ATE248601T1 (de)
AU (1) AU6387196A (de)
CA (1) CA2224697A1 (de)
DE (1) DE69629812T2 (de)
WO (1) WO1997000088A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572862B1 (en) * 1989-11-08 2003-06-03 Baylor College Of Medicine Methods and reagents to detect and characterize Norwalk and related viruses
US6673355B1 (en) * 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
US7422747B2 (en) * 1997-10-07 2008-09-09 Loma Linda University Transgenic plant-based vaccines
US20050178729A1 (en) * 1999-07-30 2005-08-18 Rabie Hamid R. Maintenance cleaning for membranes
AU2002220025A1 (en) * 2000-11-03 2002-05-15 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
AU2002230510A1 (en) * 2000-12-01 2002-06-11 American Home Products Corporation Crystal structure of rotavirus nsp4 peptide
EP2624825B1 (de) 2010-09-24 2017-06-14 University of Florida Research Foundation, Inc. Materialien und verfahren für verbesserte magen-darm-funktion
DK2814508T5 (da) 2012-02-14 2017-06-12 Merial Inc Rotavirus-underenhedsvacciner og fremgangsmåder til fremstilling og anvendelse deraf
EP2833891B1 (de) * 2012-04-05 2018-07-25 University of Florida Research Foundation, Inc. Zusammensetzung zur behandlung von zystischer fibrose und zur induktion einer ionensekretion
CN102909136B (zh) * 2012-10-29 2014-07-09 江西理工大学 一种锂辉石矿的选矿方法
JP6378307B2 (ja) 2013-03-11 2018-08-22 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 肺機能を改善するためならびに放射線誘発肺合併症の予防および／または処置のための物質および方法
WO2016115630A1 (en) * 2015-01-23 2016-07-28 Medicago Inc. Rotavirus-like particle production in plants
CN111187606B (zh) * 2020-02-25 2022-06-14 江苏海洋大学 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483779A1 (fr) 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
US4341763A (en) 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
FR2551088B1 (de) 1983-08-29 1985-12-06 Pasteur Institut
US4636385A (en) 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US4861864A (en) 1985-05-14 1989-08-29 Albert Einstein College of Medicine of Yeshiva University (a Div. of Yeshiva University) Rotavirus antigens
US4853333A (en) 1985-07-26 1989-08-01 American Home Products Corporation Production of rotavirus in yeast
US4704275A (en) 1985-08-26 1987-11-03 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases
EP0251467A3 (de) 1986-06-20 1988-07-20 Abbott Laboratories Zusammensetzungen und Verfahren zum Gebrauch eines Haupt-Aussen-Kapsid-Proteins (VP7) des Rotavirus SA-11
US5186933A (en) 1986-12-30 1993-02-16 Baylor College Of Medicine Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
US5147639A (en) 1990-06-19 1992-09-15 Ambico, Inc. Type-c rotavirus cultures and uses therefor
WO1992001784A1 (en) * 1990-07-26 1992-02-06 The Wistar Institute Of Anatomy & Biology Rotavirus reassortant vaccine
ATE170081T1 (de) 1990-11-16 1998-09-15 Childrens Hosp Medical Center Humane rotativen, impfstoffe und methoden
US6780630B1 (en) 1992-07-10 2004-08-24 Baylor College Of Medicine Parenteral immunization against rotavirus

Also Published As

Publication number Publication date
EP0833670B1 (de) 2003-09-03
JPH11507831A (ja) 1999-07-13
US6210682B1 (en) 2001-04-03
CA2224697A1 (en) 1997-01-03
WO1997000088A2 (en) 1997-01-03
AU6387196A (en) 1997-01-15
EP0833670A2 (de) 1998-04-08
DE69629812T2 (de) 2004-04-01
DE69629812D1 (de) 2003-10-09
WO1997000088A3 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
NO20022531L (no) Vaksine for forebyggelse og behandling av Alzheimer- og amyloidrelaterte sykdommer
ATE248601T1 (de) Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4
EP0652758A4 (de) Impfstoffe gegen diphtherietoxin.
AU2002302255A1 (en) Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
ATE418562T1 (de) Ctl epitope des epstein-barr virus
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
IL144265A0 (en) Use of antibodies for the vaccination against cancer
ATE193974T1 (de) Chlamydia impfstoffen
DK0762895T3 (da) Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus
ES2143996T3 (es) Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv.
DE60313437D1 (de) Mhc klasse i peptidepitope des humanen tumorassoziierten antigens 5t4
NL300112I2 (nl) Vaccin tegen dermatomycosis.
SE9700244D0 (sv) Novel antibacterial protein
DK0493575T3 (da) Vaccine af reassortant rotavirus
UA42741C2 (uk) Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти)
PT1194450E (pt) Vacina inactivada contra a calicivirose felina
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
FR2646607B1 (fr) Anticorps monoclonaux anti-b2 microglobuline
ATE305941T1 (de) Impfstoff
SE9600436D0 (sv) Vaccine against hantavirus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties